Jazz Pharmaceuticals Plc - Company Profile
Powered by 
All the data and insights you need on Jazz Pharmaceuticals Plc in one report.
$295
- Save hours of research time and resources with
our up-to-date Jazz Pharmaceuticals Plc Strategy Report
- Understand Jazz Pharmaceuticals Plc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Jazz Pharmaceuticals Plc Catalyst Calendar
Proactively evaluate Jazz Pharmaceuticals Plc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Jazz Pharmaceuticals Plc Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Dec 2019 | Phase II Trial Completion | Concert Pharmaceuticals Inc; Jazz Pharmaceuticals Plc | CNCE; JAZZ | sodium oxybate | Central Nervous System | Sleep Disorders | Clinical Trial Registry |
| 01 Nov 2019 | Phase II/III Trial Initiation | Children's Oncology Group; Jazz Pharmaceuticals Plc | JAZZ | Rylaze | Oncology | Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia); Lymphoblastic Lymphoma | Clinical Trial Registry |
| 16 Oct 2019 | Phase I/II Trial Initiation | Gilead Sciences Inc; ImmunoGen Inc; Jazz Pharmaceuticals Plc | GILD; IMGN; JAZZ | pivekimab sunirine | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Refractory Acute Myeloid Leukemia; Relapsed Acute Myeloid Leukemia | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer